Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital

The global explosion of COVID-19 necessitated the rapid dissemination of information regarding SARS-CoV-2. Hence, COVID-19 prevalence and outcome data in Parkinson's disease patients were disseminated at a time when we only had part of the picture. In this chapter we firstly discuss the current...

Descripción completa

Detalles Bibliográficos
Autores principales: Fearon, Conor, Fasano, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020798/
https://www.ncbi.nlm.nih.gov/pubmed/36208906
http://dx.doi.org/10.1016/bs.irn.2022.03.001
_version_ 1784689642907369472
author Fearon, Conor
Fasano, Alfonso
author_facet Fearon, Conor
Fasano, Alfonso
author_sort Fearon, Conor
collection PubMed
description The global explosion of COVID-19 necessitated the rapid dissemination of information regarding SARS-CoV-2. Hence, COVID-19 prevalence and outcome data in Parkinson's disease patients were disseminated at a time when we only had part of the picture. In this chapter we firstly discuss the current literature on the prevalence of COVID-19 in people with PD. We then discuss outcomes from COVID-19 in people with PD, specifically risk of hospitalization and mortality. Finally, we discuss specific contributing and confounding factors which may put PD patients at higher or lower risk from COVID-19.
format Online
Article
Text
id pubmed-9020798
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-90207982022-04-21 Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital Fearon, Conor Fasano, Alfonso Int Rev Neurobiol Article The global explosion of COVID-19 necessitated the rapid dissemination of information regarding SARS-CoV-2. Hence, COVID-19 prevalence and outcome data in Parkinson's disease patients were disseminated at a time when we only had part of the picture. In this chapter we firstly discuss the current literature on the prevalence of COVID-19 in people with PD. We then discuss outcomes from COVID-19 in people with PD, specifically risk of hospitalization and mortality. Finally, we discuss specific contributing and confounding factors which may put PD patients at higher or lower risk from COVID-19. Elsevier Inc. 2022 2022-04-20 /pmc/articles/PMC9020798/ /pubmed/36208906 http://dx.doi.org/10.1016/bs.irn.2022.03.001 Text en Copyright © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Fearon, Conor
Fasano, Alfonso
Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital
title Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital
title_full Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital
title_fullStr Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital
title_full_unstemmed Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital
title_short Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital
title_sort prevalence and outcomes of covid-19 in parkinson's disease: acute settings and hospital
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020798/
https://www.ncbi.nlm.nih.gov/pubmed/36208906
http://dx.doi.org/10.1016/bs.irn.2022.03.001
work_keys_str_mv AT fearonconor prevalenceandoutcomesofcovid19inparkinsonsdiseaseacutesettingsandhospital
AT fasanoalfonso prevalenceandoutcomesofcovid19inparkinsonsdiseaseacutesettingsandhospital

Ejemplares similares